CORD-19:e6fd10dbd99717ea319bed4c6dbc9d0a421e656c / 20322-20599 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T127","span":{"begin":0,"end":277},"obj":"Sentence"}],"text":"Serotype differences among the genetically distinct IBVs generally correlated with variations in the HVR of the S1 protein gene [4, 8] and differences of as little as 5% between S1 sequences of IBV could result in poor cross-protection offered by currently used vaccines [19] ."}

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T127","span":{"begin":0,"end":277},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Serotype differences among the genetically distinct IBVs generally correlated with variations in the HVR of the S1 protein gene [4, 8] and differences of as little as 5% between S1 sequences of IBV could result in poor cross-protection offered by currently used vaccines [19] ."}

    Epistemic_Statements

    {"project":"Epistemic_Statements","denotations":[{"id":"T16","span":{"begin":0,"end":277},"obj":"Epistemic_statement"}],"text":"Serotype differences among the genetically distinct IBVs generally correlated with variations in the HVR of the S1 protein gene [4, 8] and differences of as little as 5% between S1 sequences of IBV could result in poor cross-protection offered by currently used vaccines [19] ."}

    CORD-19-PD-MONDO

    {"project":"CORD-19-PD-MONDO","denotations":[{"id":"T55","span":{"begin":101,"end":104},"obj":"Disease"},{"id":"T83680","span":{"begin":101,"end":104},"obj":"Disease"}],"attributes":[{"id":"A55","pred":"mondo_id","subj":"T55","obj":"http://purl.obolibrary.org/obo/MONDO_0008641"},{"id":"A68444","pred":"mondo_id","subj":"T83680","obj":"http://purl.obolibrary.org/obo/MONDO_0008641"}],"text":"Serotype differences among the genetically distinct IBVs generally correlated with variations in the HVR of the S1 protein gene [4, 8] and differences of as little as 5% between S1 sequences of IBV could result in poor cross-protection offered by currently used vaccines [19] ."}